Profile data is unavailable for this security.
About the company
Respiratorius AB (publ) is a Sweden-based biotechnology and pharmaceutical company. It develops candidate drugs for treatment of cancer, Chronic Obstructive Pulmonary Disease (COPD) and asthma. The project portfolio also includes development of a biomarker for cardiovascular positron-emission tomography (PET)-imaging. The oncology drug project VAL-001 aims for first-line treatment of Diffuse Large B-Cell Lymphoma (DLBCL). In the COPD and asthma projects, the Company develops two classes of drug substances, such as RESP-1000 and RESP-2000 series for bronchodilating effect on small airways. The Company’s primary markets are the United States and South Africa.
- Revenue in SEK (TTM)1.35m
- Net income in SEK-7.26m
- Incorporated1998
- Employees--
- LocationRespiratorius AB (publ)Medicon Village, Scheelevagen 2LUND 223 81SwedenSWE
- Phone+46 709224140
- Websitehttps://www.respiratorius.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Klaria Pharma Holding AB (publ) | -6.53m | -20.10m | 49.44m | 5.00 | -- | 1.39 | -- | -- | -0.1847 | -0.4021 | -0.0621 | 0.2743 | -0.0794 | -- | -- | -1,305,600.00 | -24.44 | -37.28 | -40.23 | -51.56 | -- | -- | -- | -2,077.34 | -- | -1.87 | 0.00 | -- | -100.00 | -- | 71.17 | -- | -- | -- |
Orphazyme A/S | 0.00 | -39.68m | 50.56m | 1.00 | -- | 2.33 | -- | -- | -737.75 | -737.75 | 0.00 | 403.34 | 0.00 | -- | -- | 0.00 | -68.42 | -76.08 | -94.18 | -105.34 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 32.00 | -- | -- | -- |
Combigene AB | 3.70m | -35.24m | 61.38m | 8.00 | -- | 0.6003 | -- | 16.58 | -1.78 | -1.78 | 0.187 | 5.16 | 0.0294 | -- | 1.27 | 462,765.00 | -27.99 | -13.00 | -29.40 | -14.58 | -- | -- | -951.98 | -58.77 | -- | -- | 0.00 | -- | -79.23 | 268.58 | -479.27 | -- | -24.02 | -- |
Nidhogg Resources Holding AB (publ) | 32.00k | -13.93m | 61.65m | 3.00 | -- | -- | -- | 1,926.58 | -0.1267 | -0.1267 | 0.0003 | -0.0014 | 0.0072 | -- | 0.0134 | -- | -311.00 | -83.17 | -462.65 | -97.89 | -29,487.50 | -- | -43,525.00 | -- | -- | -818.29 | -- | -- | -- | -- | 8.95 | -- | -- | -- |
PCI Biotech Holding ASA | 2.97m | -20.15m | 66.66m | 7.00 | -- | 1.72 | -- | 22.47 | -0.5443 | -0.5443 | 0.0801 | 1.05 | 0.0556 | -- | 0.6848 | 427,142.80 | -37.78 | -36.44 | -41.97 | -40.14 | -- | -- | -679.43 | -1,055.43 | -- | -- | 0.0081 | -- | -37.05 | -20.78 | 63.13 | -- | -- | -- |
ViroGates A/S | 8.73m | -19.42m | 67.28m | 10.00 | -- | 3.29 | -- | 7.70 | -6.00 | -6.00 | 1.44 | 2.08 | 0.3344 | 0.316 | 3.64 | 573,300.00 | -74.36 | -46.58 | -80.05 | -52.09 | 77.20 | 77.91 | -222.40 | -238.01 | 10.45 | -19.08 | 0.2833 | -- | -45.01 | 10.98 | -25.40 | -- | -- | -- |
Abera Bioscience AB | 0.00 | -12.70m | 68.93m | 6.00 | -- | 7.01 | -- | -- | -0.9261 | -0.9261 | 0.00 | 0.6407 | 0.00 | -- | -- | 0.00 | -90.08 | -79.42 | -117.23 | -96.10 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 13.74 | -- | -- | -- |
Chosa Oncology AB | 73.00k | -8.92m | 69.10m | -- | -- | 3.85 | -- | 946.57 | -0.8644 | -0.8644 | 0.0017 | 0.2532 | 0.0024 | -- | 0.0103 | -- | -29.49 | -51.96 | -44.69 | -61.92 | -- | -- | -12,217.81 | -708.47 | -- | -1,453.67 | 0.00 | -- | -98.21 | -- | 28.33 | -- | -- | -- |
Respiratorius AB (publ) | 1.35m | -7.26m | 72.61m | -- | -- | 1.33 | -- | 53.92 | -0.0228 | -0.0228 | 0.0042 | 0.0776 | 0.0459 | -- | -- | -- | -24.74 | -- | -25.59 | -- | 90.84 | -- | -539.10 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -9.55 | -- |
Dextech Medical AB | 0.00 | -4.53m | 73.20m | 1.00 | -- | 2.37 | -- | -- | -0.2449 | -0.2449 | 0.00 | 1.67 | -- | -- | -- | -- | -- | -28.96 | -- | -29.94 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 12.89 | -- | 0.412 | -- |
Peptonic Medical AB | 39.05m | -45.25m | 75.24m | 37.00 | -- | 0.303 | -- | 1.93 | -0.025 | -0.025 | 0.0222 | 0.0323 | 0.4185 | 1.42 | 5.49 | 1,055,432.00 | -48.49 | -46.02 | -61.53 | -60.85 | 44.34 | 54.26 | -115.88 | -139.38 | 0.5002 | -140.41 | 0.2084 | -- | -14.93 | 149.65 | -15.55 | -- | 27.15 | -- |
Circio Holding ASA | 122.03k | -109.86m | 77.85m | 11.00 | -- | -- | -- | 637.94 | -16.08 | -16.08 | 0.0174 | -12.38 | 0.0019 | -- | 0.0072 | 11,181.82 | -172.29 | -46.58 | -- | -53.40 | -- | -- | -90,029.27 | -6,902.00 | -- | -9.82 | 7.73 | -- | -98.77 | 35.43 | 74.42 | -- | -- | -- |
Scandion Oncology A/S | 0.00 | -56.99m | 89.04m | 4.00 | -- | 0.7935 | -- | -- | -0.4286 | -0.4286 | 0.00 | 0.2668 | 0.00 | -- | -- | 0.00 | -74.59 | -- | -87.90 | -- | -- | -- | -- | -- | -- | -- | 0.0113 | -- | -- | -- | 48.89 | -- | -- | -- |
NextCell Pharma AB | 12.45m | -39.37m | 93.13m | -- | -- | 1.01 | -- | 7.48 | -0.9046 | -0.9046 | 0.286 | 1.28 | 0.1406 | 14.06 | 7.20 | -- | -44.45 | -34.92 | -50.09 | -37.06 | 12.04 | -68.21 | -316.25 | -538.60 | 4.36 | -- | 0.00 | -- | 80.96 | 72.85 | -15.21 | -- | -- | -- |
Sprint Bioscience AB | 68.36m | 8.77m | 93.56m | 36.00 | 10.67 | 3.79 | 10.03 | 1.37 | 0.1256 | 0.1256 | 0.9791 | 0.3538 | 1.58 | -- | 11.45 | 2,441,286.00 | 20.29 | -71.22 | 43.20 | -113.71 | 80.06 | 62.75 | 12.83 | -110.22 | -- | -- | 0.00 | -- | 60,725.30 | 22.99 | 99.27 | -- | -26.02 | -- |
AroCell AB (publ) | 44.79m | -56.13m | 93.99m | -- | -- | 0.6137 | -- | 2.10 | -0.2437 | -0.2437 | 0.1944 | 0.6648 | 0.2325 | 5.82 | 5.63 | -- | -29.14 | -29.25 | -31.00 | -31.37 | 1.88 | -9.85 | -125.33 | -231.19 | 5.16 | -- | 0.00 | -- | 16.37 | 122.92 | -0.5494 | -- | -- | -- |
Data as of Jul 05 2024. Currency figures normalised to Respiratorius AB (publ)'s reporting currency: Swedish Krona SEK